Histamine H3 receptor agents, preparation and therapeutic uses

Details for Australian Patent Application No. 2005252178 (hide)

Owner Eli Lilly and Company

Inventors Pickard, Richard Todd; Stevens, Freddie Craig; Beavers, Lisa Selsam; Gadski, Robert Alan; Jesudason, Cynthia Darshini

Agent Spruson & Ferguson

Pub. Number AU-B-2005252178

PCT Pub. Number WO2005/121080

Priority 60/576,421 02.06.04 US

Filing date 24 May 2005

Wipo publication date 22 December 2005

Acceptance publication date 21 April 2011

International Classifications

C07D 207/09 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4025 (2006.01) - not condensed and containing further heterocyclic rings, e.g. cromakalim

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/121080 Priority application(s): WO2005/121080

21 April 2011 Application Accepted

  Published as AU-B-2005252178

18 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005252181-Method of ink evaporation prediction for an ink reservoir

2005252175-Colored razor blades